<
Favorite pharmaceutical circulation new model Sinopharm Capital huge investment in pharmaceutical online
Release time: 2013-07-25 & nbsp & nbsp & nbsp Source: Anonymous

Recently,Industrial Fund, a subsidiary of Chinese Medicine Group, is Sinopharm Group Capital Management Co., Ltd. (referred to as & ldquo; Sinopharm Capital & RDQUO;) Recently, Zhejiang Zhencheng Pharmaceutical Online Co., Ltd. (referred to as & ldquo; medicine Online & rdquo;) Investment nearly 100 million yuan。
 
It is understood,Pharmaceutical Online is a pharmaceutical health distribution and channel value -added service stake online sports bettingStake Sports Bettingoperator based on e -commerce,Business scale is nearly 2 billion yuan。and before this,Pharmaceutical Online has obtained Huarui Investment、Many institutions, including Tonglian Capital,and twice in January 2010 and November 2011, the listing board was launched。
 
Medical circulation mode changes
 
Wu Aimin, general manager of Sinopharm Group Capital Management Co., Ltd. told reporters,The results of market competition and policy -oriented in the past made the first terminal basically by Chinese medicine、China Resources and other large central enterprises and local state -owned enterprises,The market concentration is high;、The second third terminal market, which is mainly based on the clinic, is divided by more than 10,000 small pharmaceutical wholesale companies,The average operating scale is less than 30 million yuan,Market concentration is very low,There are very few companies with nearly 2 billion yuan in sales like medicine online。
 
It is understood,At present, my country's pharmaceutical circulation industry can be roughly divided into national central enterprises、Three major camps of local state -owned enterprises and private enterprises,The first two camps are mainly positioned in the hospital terminal,Most of the private enterprises are positioned in the second and third terminals,Stake Sports BettingStake Sports BettingCompetition and evolution of the industry,Gradually formed a pure sales -based & ldquo; Chinese medicine model & rdquo; and & ldquo, which is mainly based on fast batches & rdquo;,But these two models mainly rely on strong capital forces to promote,To acquire a certain scale faucet or build a logistics base to lay out a national strategy。
 
Shen Meiqiang, chairman of Zhencheng and Rui Holding Co., Ltd.,Different from the above two modes,& ldquo; Zhencheng Mode & rdquo; Pay more attention to information construction and model optimization,Quickly integrate industry resources with light assets and virtual franchise integration concepts,Improve the efficiency of the flow of the entire industrial chain。
 
Practice & ldquo; Zhencheng Mode & rdquo;
 
and the United States、Europe and other developed countries compared to,my country's pharmaceutical circulation industry is not high,At present, there are more than 13,000 pharmaceutical wholesale companies in my country,Among them, more than 80%of the operating scale of less than 100 million yuan,With the implementation of the new version of GSP and the end of the transition period,Where will these small companies go?
 
Shen Meiqiang thinks,Take the road to merger,It will lose the opportunity to independent management,It is also difficult to get the favor of central stake online sports bettingstake sports betting appenterprises,It is estimated that 90%of companies will face the edge of elimination,But the teams and channels of these companies still have unique value。For this trend,Pharmaceutical designed & ldquo; Yunlian Qian Shang & rdquo; mode,Used to integrate small pharmaceutical business enterprises,With the new type & ldquo;,Use the Internet、Internet of Things、GIS、Cloud computing and other new generation of information technology,Integrate 1,000 local small pharmaceutical business companies in the country。
 
Wang Shaohua, Chairman of Zhejiang Zhencheng Pharmaceutical Online Co., Ltd.,Introduction of Chinese medicine capital in industry resources、Model combing and management optimization is helpful,The total investment in the next 3 years is expected to exceed 300 million yuan,Supporting business scale exceeds 10 billion yuan,and actively participate in the formulation of local standards and national standards for pharmaceutical e -commerce,Laying a solid foundation for practice & ldquo; Zhencheng mode & rdquo;。
 
In addition,Pharmaceutical Online Investment including Huarui Investment and other institutions,Although the company had previously given up the impact of the GEM,But at the same time as the Chinese medicine capital is invested,Huarui My stake betting appstake betting appinvestment increases by 2.5%of the shares at the same time。